Based on 27 analysts giving stock ratings to Zimmer Biomet Holdings Inc in the past month.
In the current month, ZBH has received 5 Buy Ratings, 20 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the last month is 106.635.
Based on analysts' estimates, ZBH EPS is projected to reach 2.490 in FY2026Q4, following reported EPS of 1.006 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD 1.01, while Zimmer Biomet Holdings IncZBH's earnings per share (EPS) for the previous quarter was USD 1.03. EPS for the next quarter is expected at USD 2.49.